Clinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.
The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.
由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的冠状病毒疾病(COVID-19)大流行正在导致大量发病和死亡。在 COVID-19 患者中,年龄较大以及存在糖尿病、高血压和肥胖症显著增加了住院和死亡的风险。在这篇观点文章中,我们根据对 SARS-CoV-2、中东呼吸综合征(MERS-CoV)的研究以及目前关于 SARS-CoV-2 的文献,讨论了糖尿病调节宿主-病毒相互作用和宿主免疫反应的潜在机制。我们希望强调需要进一步研究糖尿病患者 COVID-19 的相关知识空白。